Aptose Biosciences Faces NASDAQ Delisting Notice
Ticker: APTOF · Form: 8-K · Filed: Apr 3, 2025 · CIK: 882361
Sentiment: bearish
Topics: delisting, listing-standards, sec-filing
Related Tickers: APTO
TL;DR
Aptose Biosciences got a NASDAQ delisting notice, effective March 31st. Big trouble ahead?
AI Summary
Aptose Biosciences Inc. filed an 8-K on April 3, 2025, reporting a notice of delisting or failure to meet continued listing standards with NASDAQ, effective March 31, 2025. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and headquartered in Toronto.
Why It Matters
This filing indicates potential delisting from NASDAQ, which could significantly impact the company's stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on a major exchange.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- NASDAQ (company) — Exchange
- March 31, 2025 (date) — Effective date of notice
- April 3, 2025 (date) — Filing date
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
FAQ
What specific continued listing rule or standard did Aptose Biosciences Inc. fail to satisfy?
The filing does not specify the exact rule or standard that Aptose Biosciences Inc. failed to satisfy, only that it received a notice of delisting or failure to meet such standards.
What is the effective date of the delisting notice?
The earliest event reported, which is the notice of delisting or failure to satisfy a continued listing rule or standard, was effective as of March 31, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on April 3, 2025.
What were Aptose Biosciences Inc.'s former names?
Aptose Biosciences Inc. was formerly known as Lorus Therapeutics Inc. and prior to that, Imutec Pharma Inc.
Where is Aptose Biosciences Inc. incorporated and headquartered?
Aptose Biosciences Inc. is incorporated in Canada and its business address is in Toronto, Canada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Aptose Biosciences Inc. (APTOF).